ERGO Capital Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 2
- Investments
- 13
- Portfolio
- 8
- Exits
- 6
ERGO Capital General Information
Description
Ergo Capital is an investment firm that provides equity and debt financing for growth stage companies. Ergo Accel, on the other hand, focuses on seed and pre-seed startup investments. The firm invests in private companies in tech and other high-growth sectors. It was founded in 2010 and is based in Irvine, California.
Contact Information
Website
Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Lender/Debt Provider
Growth/Expansion
Primary Office
- 1621 Alton Parkway
- Suite 250
- Irvine, CA 92606
- United States
ERGO Capital Investments (13)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Axis (Electronics (B2C)) | 18-Mar-2018 | Later Stage VC | 00000 | Electronics (B2C) | Generating Revenue | |
| 00000000 | 31-May-2017 | 00000 00000 | 000.00 | Electronics (B2C) | Generating Revenue | |
| 0000 | 17-Apr-2017 | 000000000000 | 0000 | Application Software | Generating Revenue | |
| 0000 000000000 | 07-Dec-2016 | 0000 | 000 | Outcome Management (Healthcare) | Generating Revenue | |
| 0000 00000000 | 31-May-2015 | 000000 00000 | 00.00 | Other Communications and Networking | Generating Revenue/Not Profitable | |
| 000000 0000 | 15-Apr-2015 | 0000 00000 | 00000 | Internet Retail | Out of Business | |
| 0000000 | 16-Jan-2013 | 00000 00000 | 000 | Road | Profitable | |
| 000000 00000000 | 01-Nov-2010 | 00000 00000 | 00.00 | Pharmaceuticals | Generating Revenue/Not Profitable | |
| Cretan Hybrid Energies | Early Stage VC | Energy Production | Startup | |||
| Pulse & Opinion | Early Stage VC | Media and Information Services (B2B) | Profitable |
ERGO Capital Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| MYnd Analytics | 17-Jul-2019 | Merger/Acquisition | |
| 0000000 | 01-Apr-2019 | 000 00 00000000 | |
| 000000 0000 | 01-Nov-2017 | 000 00 00000000 | |
| Pulstar | 26-Jul-2016 | Buyout/LBO | |
| Cancer Genetics | 05-Apr-2013 | IPO | 000 |
ERGO Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialERGO Capital Team (8)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Peter Polydor | Chief Executive Officer | Santa Ana, CA | |||
| Tookie Graham | Analyst and Mentor | Santa Ana, CA | |||
| Alan Sellers | Advisor | Santa Ana, CA | |||
| David Wright | Advisor | Santa Ana, CA | |||
| George Kallins MD | Advisor | Santa Ana, CA |
ERGO Capital Co-Investors (11)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Angel One Investor Network | 1 |
|
|
||
| California Technology Ventures | 0 |
|
|
||
| NorthSpring Capital Partners | 0 |
|
|
||
| Sustainable Development Technology Canada | 0 |
|
|
||
| TransLink Capital | 0 | 0 |
|
|